Table 2 Adjusting for gender, age, targeted and immunotherapy (multivariate analysis)
From: Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma
(1) | (2) | (3) | (4) | |
|---|---|---|---|---|
ECP > 16 | 1.869* (0.893, 3.913) | 1.869* (0.893, 3.913) | 1.873* (0.895, 3.918) | 1.300 (0.578, 2.922) |
gender | 0.999 (0.482, 2.074) | 0.987 (0.475, 2.053) | 0.692 (0.311, 1.538) | |
age | 1.006 (0.977, 1.035) | 1.008 (0.978, 1.039) | ||
Targeted therapy | 0.728 (0.318, 1.663) | |||
Immunotherapy | 0.327** (0.130, 0.826) | |||
Observations | 56 | 56 | 56 | 56 |
R2 | 0.050 | 0.050 | 0.053 | 0.146 |
Max. Possible R2 | 0.982 | 0.982 | 0.982 | 0.982 |
Log Likelihood | − 110.967 | −110.967 | −110.893 | −107.992 |
Wald Test | 2.760* (df = 1) | 2.760 (df = 2) | 2.900 (df = 3) | 7.910 (df = 5) |
LR Test | 2.894* (df = 1) | 2.894 (df = 2) | 3.044 (df = 3) | 8.846 (df = 5) |
Score (Logrank) Test | 2.841* (df = 1) | 2.841 (df = 2) | 2.985 (df = 3) | 8.503 (df = 5) |